Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"WHO International Clinical Trials Registry Platform"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Dexamethasone%22&type=AllFields&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22
/vufind/Search/Results?lookfor=%22Dexamethasone%22&type=AllFields&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22
Search /vufind/Search2/Results?lookfor=%22Dexamethasone%22&type=AllFields&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22
PubPharm (5.434)
1
Evaluation of pomalidomide with dexamethasone (low dose) in patients with Multiple Myeloma (MM)whose disease did not respond to the previous treatment or, has come back after the previous treatment. : A MULTICENTER, SINGLE-ARM, OPEN-LABEL STUDY WITH POMALIDOMIDE IN COMBINATION WITH LOW DOSE DEXAMETHASONE IN SUBJECTS WITH REFRACTORY OR RELAPSED AND REFRACTORY MULTIPLE MYELOMA
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
Study of Rituximab and Ibrutinib (RI) versus Dexamethasone, Rituximab and Cyclophosphamide (DRC) as initial therapy for Waldenström's macroglobulinaemia : Randomised phase II/III study of Rituximab and Ibrutinib (RI) versus Dexamethasone, Rituximab and Cyclophosphamide (DRC) as initial therapy for Waldenström's macroglobulinaemia - RAINBOW
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
A study to assess the safety and efficacy of dexamethasone plus MLN9708 or physician choice of treatment in patients with relapsed or refractory amyloidosis. : A Phase 3 Randomized, Controlled, Open-label, Multicenter, Safety and Efficacy Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment Administered to Patients With Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
SHP640 in the Treatment of Adenoviral Conjunctivitis : A Phase 3, Multi-center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of SHP640 (PVP-Iodine 0.6% and Dexamethasone 0.1%) Ophthalmic Suspension Compared to PVP-Iodine and Placebo in the Treatment of Adenoviral Conjunctivitis
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
Bortezomib, Selinexor and Dexamethasone in Patients with Multiple Myeloma : A Phase 3 Randomized, Controlled, Open-label Study of Selinexor, Bortezomib, and Dexamethasone (SVd) versus Bortezomib and Dexamethasone (Vd) in Patients with Relapsed or Refractory Multiple Myeloma (RRMM) - BOSTON
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
6
A Clinical Study of Daratumumab Subcutaneous (Dara-SC) Administration in Combination with Carfilzomib and Dexamethasone (DKd) Compared with Carfilzomib and Dexamethasone (Kd) in Participants with Multiple Myeloma who have been Previously Treated with Daratumumab Intravenous (Dara-IV) to Evaluate Daratumumab Retreatment : A Phase 2 Study of Daratumumab Subcutaneous (Dara-SC) Administration in Combination with Carfilzomib and Dexamethasone (DKd) Compared with Carfilzomib and Dexamethasone (Kd) in Participants with Multiple Myeloma who have been Previously Treated with Daratumumab Intravenous (Dara-IV) to Evaluate Daratumumab Retreatment
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
7
Evaluation of pomalidomide with dexamethasone (low dose) in patients with Multiple Myeloma (MM)whose disease did not respond to the previous treatment or, has come back after the previous treatment. : A MULTICENTER, SINGLE-ARM, OPEN-LABEL STUDY WITH POMALIDOMIDE IN COMBINATION WITH LOW DOSE DEXAMETHASONE IN SUBJECTS WITH REFRACTORY OR RELAPSED AND REFRACTORY MULTIPLE MYELOMA
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
8
Evaluation of pomalidomide with dexamethasone (low dose) in patients with Multiple Myeloma (MM)whose disease did not respond to the previous treatment or, has come back after the previous treatment. : A MULTICENTER, SINGLE-ARM, OPEN-LABEL STUDY WITH POMALIDOMIDE IN COMBINATION WITH LOW DOSE DEXAMETHASONE IN SUBJECTS WITH REFRACTORY OR RELAPSED AND REFRACTORY MULTIPLE MYELOMA
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
9
Evaluation of pomalidomide with dexamethasone (low dose) in patients with Multiple Myeloma (MM)whose disease did not respond to the previous treatment or, has come back after the previous treatment. : A MULTICENTER, SINGLE-ARM, OPEN-LABEL STUDY WITH POMALIDOMIDE IN COMBINATION WITH LOW DOSE DEXAMETHASONE IN SUBJECTS WITH REFRACTORY OR RELAPSED AND REFRACTORY MULTIPLE MYELOMA
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
10
Evaluation of pomalidomide with dexamethasone (low dose) in patients with Multiple Myeloma (MM)whose disease did not respond to the previous treatment or, has come back after the previous treatment. : A MULTICENTER, SINGLE-ARM, OPEN-LABEL STUDY WITH POMALIDOMIDE IN COMBINATION WITH LOW DOSE DEXAMETHASONE IN SUBJECTS WITH REFRACTORY OR RELAPSED AND REFRACTORY MULTIPLE MYELOMA
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[544]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Zeitschrift: WHO International Clinical Trials Registry Platform
Medienart
5.434
Aufsätze
5.434
E-Artikel
5.434
E-Ressourcen
Zeitschriftentitel
WHO International Clinical Trials Registry Plat...
Thema
5.412
610
5.250
Study Type: Interventional
2.180
Recruitment Status: Not yet recruiting
1.318
Phase: Phase 3
1.040
Recruitment Status: Authorised-recruitment may ...
1.020
Recruitment Status: Completed
832
Recruitment Status: Recruiting
794
Phase: Phase 2
308
Phase: Phase 4
190
Phase: Phase 2/Phase 3
180
Recruitment Status: Complete: follow-up complete
174
Medical Condition: Health Condition 1: O- Medic...
170
Phase: Phase 1
134
Medical Condition: Multiple Myeloma MedDRA vers...
132
Study Type: Observational
82
Medical Condition: Multiple Myeloma
56
Medical Condition: Multiple myeloma MedDRA vers...
54
Medical Condition: Multiple myeloma
48
Phase: Other
46
Medical Condition: multiple myeloma
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
3.474
2020-
1.960
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
5.316
Englisch
98
Unbestimmt
10
Französisch
4
Dänisch
4
Spanisch
2
Deutsch
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...